MedPath

Provision of supplementary pain relief and pre-emptive analgesia by injecting anesthetic drug in the pecto-intercostal fascial plane under ultrasound guidance for patients undergoing cardiac surgeries.

Not Applicable
Conditions
Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Registration Number
CTRI/2019/10/021591
Lead Sponsor
Shree Chitra Tirunal Institute for Medical Sciences and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion criteria

Adult patients coming for elective cardiac

surgery having CAD for CABG.

> 40 years old and < 75 years old

Median sternotomy

Patient undergoing Coronary Artery bypass

surgery.

Exclusion Criteria

Emergency Surgeries.

Redo-surgeries.

Open Sternum

Left Ventricular Ejection Fraction < 35%

Preoperative use of narcotics or illicit drug

abuse.

History of chronic intractable non-cardiac pain.

Liver or Kidney disease

Allergy to Amide group of anaesthetics, Morphine

or Fentanyl.

Arrhythmia history or rhythm disturbances

documented in ECG.

Haemodynamically unstable patients, already on

preoperative inotropic support or Intraarterial

balloon pumps(IABP).

Anticipated surgery or Surgery lasting more than

6hrs.

Patient on ventilator time more than 12hrs or

planned for overnight ventilation.

Patients refusing to participate.

Patients refusing for parting with medical data

for analysis.

Patients refusing to participate after the start

of study and desire to leave the study at any

point of time.

Patients currently enrolled in another study.

Patients with inability to provide informed

written consent.

Inability to complete Pain assessments.

Post-operative complications with underlying

cardio-respiratory cause requiring return to

operative room for re-explorations or

reinstitution of mechanical ventilation.

Patients refusing the offered therapeutic

options in either group.

No bias against gender, class, caste, ethnicity,

race and will be considered as inclusion or

exclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath